VAXCYTE, INC. Class of Warrant or Right, Number of Securities Called by Warrants or Rights
VAXCYTE, INC. (PCVX) had Class of Warrant or Right, Number of Securities Called by Warrants or Rights of 5.46 million shares as of 2026-03-31, per its 10-Q filed 2026-05-06.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights · last filed 2026-05-06
- 2026-03-31: Class of Warrant or Right, Number of Securities Called by Warrants or Rights 5.46M shares.
- 2025-12-31: Class of Warrant or Right, Number of Securities Called by Warrants or Rights 5.46M shares.
- 2025-03-31: Class of Warrant or Right, Number of Securities Called by Warrants or Rights 3.50M shares.
| Period end | Class of Warrant or Right, Number of Securities Called by Warrants or Rights |
|---|---|
| 2026-03-31 | 5.46M shares 10-Q · filed 2026-05-06 |
| 2025-12-31 | 5.46M shares 10-Q · filed 2026-05-06 |
| 2025-03-31 | 3.50M shares 10-Q · filed 2026-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |